Search - tctmd.com

Displaying 741 - 760 of 849

Sort: Relevancy | Date

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

News Daily News

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

L.A. McKeown

January 12, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

Presentation TCT 2012

Methods of measurement of aspirin-mediated antiplatelet. Degree of correlation and agreement between two “point of care: VerifyNow®Aspirin assay and PFA-100®

Presenter: Jose Maria Cubero Gomez, Maria Asunci?n Navarro Puerto, Maria Isabel De Mier Barragan, Francisco J. Sanchez-Burguillos, Pastor L. Perez-Santigosa, Francisco J. Molano Casimiro, Luis F. Pastor Torres

January 03, 2012

News Daily News

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

January 03, 2012

News Daily News

New-Onset A-fib After Percutaneous Valve Repair More Common Than Thought

December 13, 2011

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Conference News

SPICE: Esomeprazole Reduces Antiplatelet Effect of Clopidogrel

November 21, 2011

News Daily News

CAS for Acute Stroke Feasible - But Controversial

Leah Lawrence

November 20, 2011

News Conference News

Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity

November 17, 2011

News Conference News

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

November 13, 2011

News Conference News

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

November 09, 2011

News Conference News

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

November 09, 2011

News Conference News

ZES and SES Equally Effective in Long Lesion Treatment

November 08, 2011

News Industry News

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

November 08, 2011

News Industry News

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

November 08, 2011

News Conference News

Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients

November 08, 2011

News Conference News

Coronary Heart Disease Mortality Down, But Prevention Efforts Still Needed

November 08, 2011

Advertisement

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Methods of measurement of aspirin-mediated antiplatelet. Degree of correlation and agreement between two “point of care: VerifyNow®Aspirin assay and PFA-100®

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

New-Onset A-fib After Percutaneous Valve Repair More Common Than Thought

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

SPICE: Esomeprazole Reduces Antiplatelet Effect of Clopidogrel

CAS for Acute Stroke Feasible - But Controversial

Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

ZES and SES Equally Effective in Long Lesion Treatment

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients

Coronary Heart Disease Mortality Down, But Prevention Efforts Still Needed

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content